NRXP

NRX Pharmaceuticals (NRXP)

About NRX Pharmaceuticals (NRXP)

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.

Details

Daily high

$2.12

Daily low

$1.96

Price at open

$2.11

52 Week High

$6.01

52 Week Low

$1.10

Market cap

35.1M

Dividend yield

0.00%

Volume

70,451

Avg. volume

101,413

P/E ratio

-.85

NRX Pharmaceuticals News